CRNX Crinetics Pharmaceuticals In

held by 1 manager in Q1 2024

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.39%	3 mo	NEW	$14M	309,000

Search